Validity of wearable actimeter computation of total energy expenditure during walking in post-stroke individuals.


Journal

Annals of physical and rehabilitation medicine
ISSN: 1877-0665
Titre abrégé: Ann Phys Rehabil Med
Pays: Netherlands
ID NLM: 101502773

Informations de publication

Date de publication:
May 2020
Historique:
received: 08 01 2019
revised: 02 07 2019
accepted: 05 07 2019
pubmed: 14 8 2019
medline: 27 3 2021
entrez: 14 8 2019
Statut: ppublish

Résumé

Recent studies reported that wearable sensor devices show low validity for assessing the amount of energy expenditure in individuals after stroke. We aimed to evaluate the validity of energy expenditure calculation based on the product of energy cost and walked distance estimated by wearable devices in individuals after hemispheric stroke. We recruited individuals with hemispheric stroke sequelae who were able to walk without human assistance. The participants wore a tri-axial accelerometer (Actigraph GT3x) and a pedometer (ONStep 400) on the unaffected hip in addition to a respiratory gas exchange analyzer (METAMAX 3B) during 6min of walking at their self-selected walking speed and mode. The energy expenditure was calculated from the product of energy cost measured by the METAMAX 3B and the distance estimated by wearable devices. It was compared to the energy expenditure measured by the METAMAX 3B and the energy expenditure values recorded by the devices according to the manufacturer's algorithms. The validity was investigated by Bland-Altman analysis (mean bias [MB], root mean square error [RMSE], limits of agreement [95%LoA]), and Pearson correlation analysis (r). We included 26 participants (mean [SD] age 64.6 [14.8] years). With the pedometer, the energy expenditure calculated from the product of energy cost and walked distance showed high accuracy and agreement with METAMAX 3B values (MB=-1.6kcal; RMSE=4.1kcal; 95%LoA=-9.9; 6.6kcal; r=0.87, P<0.01) but low accuracy and agreement with Actigraph GT3x values (MB=15.7kcal; RMSE=8.7kcal; 95%LoA=-1.3; 32.6kcal; r=0.44, P=0.02) because of poorer estimation of walked distance. With the pedometer, this new method of calculation strongly increased the validity parameter values for estimating energy expenditure as compared with the manufacturer's algorithm. This new method based on the energy cost and distance estimated by wearable devices provided better energy expenditure estimates for the pedometer than did the manufacturer's algorithm. The validity of this method depended on the accuracy of the sensor to measure the distance walked by an individual after stroke.

Sections du résumé

BACKGROUND BACKGROUND
Recent studies reported that wearable sensor devices show low validity for assessing the amount of energy expenditure in individuals after stroke.
OBJECTIVE OBJECTIVE
We aimed to evaluate the validity of energy expenditure calculation based on the product of energy cost and walked distance estimated by wearable devices in individuals after hemispheric stroke.
METHODS METHODS
We recruited individuals with hemispheric stroke sequelae who were able to walk without human assistance. The participants wore a tri-axial accelerometer (Actigraph GT3x) and a pedometer (ONStep 400) on the unaffected hip in addition to a respiratory gas exchange analyzer (METAMAX 3B) during 6min of walking at their self-selected walking speed and mode. The energy expenditure was calculated from the product of energy cost measured by the METAMAX 3B and the distance estimated by wearable devices. It was compared to the energy expenditure measured by the METAMAX 3B and the energy expenditure values recorded by the devices according to the manufacturer's algorithms. The validity was investigated by Bland-Altman analysis (mean bias [MB], root mean square error [RMSE], limits of agreement [95%LoA]), and Pearson correlation analysis (r).
RESULTS RESULTS
We included 26 participants (mean [SD] age 64.6 [14.8] years). With the pedometer, the energy expenditure calculated from the product of energy cost and walked distance showed high accuracy and agreement with METAMAX 3B values (MB=-1.6kcal; RMSE=4.1kcal; 95%LoA=-9.9; 6.6kcal; r=0.87, P<0.01) but low accuracy and agreement with Actigraph GT3x values (MB=15.7kcal; RMSE=8.7kcal; 95%LoA=-1.3; 32.6kcal; r=0.44, P=0.02) because of poorer estimation of walked distance. With the pedometer, this new method of calculation strongly increased the validity parameter values for estimating energy expenditure as compared with the manufacturer's algorithm.
CONCLUSIONS CONCLUSIONS
This new method based on the energy cost and distance estimated by wearable devices provided better energy expenditure estimates for the pedometer than did the manufacturer's algorithm. The validity of this method depended on the accuracy of the sensor to measure the distance walked by an individual after stroke.

Identifiants

pubmed: 31408710
pii: S1877-0657(19)30111-3
doi: 10.1016/j.rehab.2019.07.002
pii:
doi:

Types de publication

Comparative Study Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

209-215

Informations de copyright

Copyright © 2019. Published by Elsevier Masson SAS.

Auteurs

M Compagnat (M)

HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), IFRH, University of Limoges, 87042 Limoges, France; Department of Physical Medicine and Rehabilitation in the University Hospital Center of Limoges, 87042 Limoges, France. Electronic address: maxence.compagnat@icloud.com.

S Mandigout (S)

HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), IFRH, University of Limoges, 87042 Limoges, France. Electronic address: stephane.mandigout@unilim.fr.

C S Batcho (CS)

Center for interdisciplinary research in rehabilitation and social integration (CIRRIS), Centre intégré universitaire de santé et de services sociaux de la Capitale Nationale (CIUSSS-CN), Quebec, Canada; Department of Rehabilitation, Faculty of Medicine, Université Laval, Quebec, Canada. Electronic address: charles.batcho@fmed.ulaval.ca.

N Vuillerme (N)

AGEIS, University Grenoble-Alpes, 38706 Grenoble, France; Institut Universitaire de France, 75000 Paris, France. Electronic address: nicolas.vuillerme@univ-grenoble-alpes.fr.

J Y Salle (JY)

HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), IFRH, University of Limoges, 87042 Limoges, France; Department of Physical Medicine and Rehabilitation in the University Hospital Center of Limoges, 87042 Limoges, France. Electronic address: jean-yves.salle@chu-limoges.fr.

R David (R)

Department of Physical Medicine and Rehabilitation in the University Hospital Center of Limoges, 87042 Limoges, France. Electronic address: romain-david@hotmail.fr.

J C Daviet (JC)

HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), IFRH, University of Limoges, 87042 Limoges, France; Department of Physical Medicine and Rehabilitation in the University Hospital Center of Limoges, 87042 Limoges, France. Electronic address: jean-christophe.daviet@unilim.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH